Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Giovanni de Gaetano.
Archive | 2007
Lodovico Balducci; William B. Ershler; Giovanni de Gaetano
The developed world has an increasingly aging population, with approximately 10% of the population aged over 65 years. As the incidence and prevalence of blood disorders increases with age, these conditions are a heavy burden on healthcare systems. Blood Disorders in the Elderly will provide hematologists, geriatricians, and all clinicians involved in the care of patients with blood disorders with clear clinical advice on the diagnosis and management of these conditions. The introductory section reviews the epidemiology of aging and anemia, and provides a comprehensive approach to the management of cancer in the aging patient. This is followed by a full discussion of hematopoiesis and the changes it undergoes in aging. The remaining sections cover the diagnosis and management of all major disorders: anemia, malignancy, and hemostasis disorders, including hemophilia. A detailed chapter on antithrombotic therapies is also included.
Archive | 2007
Lodovico Balducci; William B. Ershler; Giovanni de Gaetano
The developed world has an increasingly aging population, with approximately 10% of the population aged over 65 years. As the incidence and prevalence of blood disorders increases with age, these conditions are a heavy burden on healthcare systems. Blood Disorders in the Elderly will provide hematologists, geriatricians, and all clinicians involved in the care of patients with blood disorders with clear clinical advice on the diagnosis and management of these conditions. The introductory section reviews the epidemiology of aging and anemia, and provides a comprehensive approach to the management of cancer in the aging patient. This is followed by a full discussion of hematopoiesis and the changes it undergoes in aging. The remaining sections cover the diagnosis and management of all major disorders: anemia, malignancy, and hemostasis disorders, including hemophilia. A detailed chapter on antithrombotic therapies is also included.
Archive | 2007
Lodovico Balducci; William B. Ershler; Giovanni de Gaetano
The developed world has an increasingly aging population, with approximately 10% of the population aged over 65 years. As the incidence and prevalence of blood disorders increases with age, these conditions are a heavy burden on healthcare systems. Blood Disorders in the Elderly will provide hematologists, geriatricians, and all clinicians involved in the care of patients with blood disorders with clear clinical advice on the diagnosis and management of these conditions. The introductory section reviews the epidemiology of aging and anemia, and provides a comprehensive approach to the management of cancer in the aging patient. This is followed by a full discussion of hematopoiesis and the changes it undergoes in aging. The remaining sections cover the diagnosis and management of all major disorders: anemia, malignancy, and hemostasis disorders, including hemophilia. A detailed chapter on antithrombotic therapies is also included.
Archive | 2007
Lodovico Balducci; William B. Ershler; Giovanni de Gaetano
The developed world has an increasingly aging population, with approximately 10% of the population aged over 65 years. As the incidence and prevalence of blood disorders increases with age, these conditions are a heavy burden on healthcare systems. Blood Disorders in the Elderly will provide hematologists, geriatricians, and all clinicians involved in the care of patients with blood disorders with clear clinical advice on the diagnosis and management of these conditions. The introductory section reviews the epidemiology of aging and anemia, and provides a comprehensive approach to the management of cancer in the aging patient. This is followed by a full discussion of hematopoiesis and the changes it undergoes in aging. The remaining sections cover the diagnosis and management of all major disorders: anemia, malignancy, and hemostasis disorders, including hemophilia. A detailed chapter on antithrombotic therapies is also included.
Archive | 2007
Lodovico Balducci; William B. Ershler; Giovanni de Gaetano
The developed world has an increasingly aging population, with approximately 10% of the population aged over 65 years. As the incidence and prevalence of blood disorders increases with age, these conditions are a heavy burden on healthcare systems. Blood Disorders in the Elderly will provide hematologists, geriatricians, and all clinicians involved in the care of patients with blood disorders with clear clinical advice on the diagnosis and management of these conditions. The introductory section reviews the epidemiology of aging and anemia, and provides a comprehensive approach to the management of cancer in the aging patient. This is followed by a full discussion of hematopoiesis and the changes it undergoes in aging. The remaining sections cover the diagnosis and management of all major disorders: anemia, malignancy, and hemostasis disorders, including hemophilia. A detailed chapter on antithrombotic therapies is also included.
Archive | 2007
Lodovico Balducci; William B. Ershler; Giovanni de Gaetano
The developed world has an increasingly aging population, with approximately 10% of the population aged over 65 years. As the incidence and prevalence of blood disorders increases with age, these conditions are a heavy burden on healthcare systems. Blood Disorders in the Elderly will provide hematologists, geriatricians, and all clinicians involved in the care of patients with blood disorders with clear clinical advice on the diagnosis and management of these conditions. The introductory section reviews the epidemiology of aging and anemia, and provides a comprehensive approach to the management of cancer in the aging patient. This is followed by a full discussion of hematopoiesis and the changes it undergoes in aging. The remaining sections cover the diagnosis and management of all major disorders: anemia, malignancy, and hemostasis disorders, including hemophilia. A detailed chapter on antithrombotic therapies is also included.
Archive | 2007
Magda Melchert; Jeffrey E. Lancet; Lodovico Balducci; William B. Ershler; Giovanni de Gaetano
Archive | 2007
Lodovico Balducci; William B. Ershler; Giovanni de Gaetano
Archive | 2007
Giovanni de Gaetano; William B. Ershler; Lodovico Balducci
Archive | 2007
Lodovico Balducci; William B. Ershler; Giovanni de Gaetano